Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
Meagan P. O’Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo-Chen Chan, Bret J. Musser, Katharine J. Bar, Ruanne V. Barnabas, Dan H. Barouch, Myron S. Cohen, Christopher B. Hurt, Dale R. Burwen, Mary A. Marovich, Elizabeth R. Brown, Ingeborg Heirman, John D. Davis, Kenneth C. Turner, Divya Ramesh, Adnan Mahmood, Andrea T. Hooper, Jennifer D. Hamilton, Yunji Kim, Lisa A. Purcell, Alina Baum, Christos A. Kyratsous, James Krainson, Richard Perez-Perez, Rizwana Mohseni, Bari Kowal, A. Thomas DiCioccio, Neil Stahl, Leah Lipsich, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the COVID-19 Phase 3 Prevention Trial Team
doi: https://doi.org/10.1101/2021.06.14.21258569
Meagan P. O’Brien
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D.Eduardo Forleo-Neto
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D.Neena Sarkar
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Flonza Isa
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D.Peijie Hou
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Kuo-Chen Chan
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Bret J. Musser
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Katharine J. Bar
2Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA
M.D.Ruanne V. Barnabas
3Department of Global Health, University of Washington, Seattle, WA, USA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
M.D.Dan H. Barouch
4Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
M.D., Ph.D.Myron S. Cohen
5Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA
M.D.Christopher B. Hurt
5Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA
M.D.Dale R. Burwen
6National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA
M.D., M.P.H.Mary A. Marovich
6National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA
M.D.Elizabeth R. Brown
7Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA
Sc.D.Ingeborg Heirman
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.John D. Davis
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Kenneth C. Turner
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Divya Ramesh
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Adnan Mahmood
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D.Andrea T. Hooper
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Jennifer D. Hamilton
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Yunji Kim
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Pharm.D.Lisa A. Purcell
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Alina Baum
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Christos A. Kyratsous
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.James Krainson
8Clinical Trials of Florida, LLC, Miami, FL, USA
M.D., C.P.I., R.P.S.G.T.Richard Perez-Perez
9Medical Research of Westchester, Miami, FL, USA
M.D.Rizwana Mohseni
10Catalina Research Institute, LLC, Montclair, CA, USA
D.O.Bari Kowal
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.S.A. Thomas DiCioccio
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Neil Stahl
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Leah Lipsich
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
Ph.D.Ned Braunstein
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D.Gary Herman
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D.George D. Yancopoulos
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D., Ph.D.David M. Weinreich
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
M.D.Data Availability
Qualified researchers may request access to study documents (including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan) that support the methods and findings reported in this manuscript. Individual anonymized participant data will be considered for sharing once the indication has been approved by a regulatory body, if there is legal authority to share the data and there is not a reasonable likelihood of participant re-identification. Submit requests to https://vivli.org/.
Posted September 18, 2021.
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
Meagan P. O’Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo-Chen Chan, Bret J. Musser, Katharine J. Bar, Ruanne V. Barnabas, Dan H. Barouch, Myron S. Cohen, Christopher B. Hurt, Dale R. Burwen, Mary A. Marovich, Elizabeth R. Brown, Ingeborg Heirman, John D. Davis, Kenneth C. Turner, Divya Ramesh, Adnan Mahmood, Andrea T. Hooper, Jennifer D. Hamilton, Yunji Kim, Lisa A. Purcell, Alina Baum, Christos A. Kyratsous, James Krainson, Richard Perez-Perez, Rizwana Mohseni, Bari Kowal, A. Thomas DiCioccio, Neil Stahl, Leah Lipsich, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the COVID-19 Phase 3 Prevention Trial Team
medRxiv 2021.06.14.21258569; doi: https://doi.org/10.1101/2021.06.14.21258569
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
Meagan P. O’Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo-Chen Chan, Bret J. Musser, Katharine J. Bar, Ruanne V. Barnabas, Dan H. Barouch, Myron S. Cohen, Christopher B. Hurt, Dale R. Burwen, Mary A. Marovich, Elizabeth R. Brown, Ingeborg Heirman, John D. Davis, Kenneth C. Turner, Divya Ramesh, Adnan Mahmood, Andrea T. Hooper, Jennifer D. Hamilton, Yunji Kim, Lisa A. Purcell, Alina Baum, Christos A. Kyratsous, James Krainson, Richard Perez-Perez, Rizwana Mohseni, Bari Kowal, A. Thomas DiCioccio, Neil Stahl, Leah Lipsich, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the COVID-19 Phase 3 Prevention Trial Team
medRxiv 2021.06.14.21258569; doi: https://doi.org/10.1101/2021.06.14.21258569
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2833)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12534)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2840)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)